跳至主要内容
临床试验/NCT00700791
NCT00700791终止早期 1 期

Efficacy of Natural Vitamin E Tocotrienol on the Treatment of Surgical Scars

Chandan K Sen4 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2008年7月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
终止
发起方
入组人数
168
试验地点
4
主要终点
1.To determine the efficacy of TCT in improving the appearance of post-surgical scars following oral supplementation 2.To determine the efficacy of TCT in improving the appearance of post-surgical scars following topical application

研究概览

简要总结

The overall goal of this study is to determine the efficacy of tocotrienol (TCT), a natural form of vitamin E, in preventing or reducing scar formation in human skin wounds as well as the basal levels of TCT in normal human skin and adipose tissue.

详细描述

Scar formation is the physiological and inevitable end point of mammalian wound healing and there is substantial evidence that inflammation is an essential prerequisite for scarring. Although scar tissue restores the normal skin barrier, the new tissue is inferior in structural, aesthetic, and functional respects. The mammalian wound healing response may have originated during the time of high susceptibility to infection. Therefore, we may have developed speed optimized wound healing where a multiple redundant compensating rapid inflammatory response allows the wound to heal quickly without infection. The scar is then the price mammals have to pay for evolutionary survival after being wounded.

Tocotrienol may be an effective tool to prevent or reduce normal, hypertrophic, or keloid scarring by mediating the inflammatory response. Tocotrienol is a safe and convenient treatment that could be used by mouth or topically. There has never been a study on the effectiveness of tocotrienol in preventing or reducing scar formation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older.
  • Non- smoker
  • No current medications that alter liver metabolism (e.g., Phenobarbital, HmG co-A inhibitors, etc.)
  • Non- pregnant or non-breastfeeding
  • No current use of dietary supplements containing vitamin-E
  • Not actively abusing drugs or alcohol

排除标准

  • Under 18 years of age
  • Prisoners
  • Current smoker
  • Pregnant or breastfeeding
  • HIV diagnosis
  • Viral hepatitis diagnosis
  • Immunosuppressive therapy
  • Actively abusing drugs or alcohol
  • Current use of dietary supplements containing vitamin-E

结局指标

主要结局

1.To determine the efficacy of TCT in improving the appearance of post-surgical scars following oral supplementation 2.To determine the efficacy of TCT in improving the appearance of post-surgical scars following topical application

时间窗: 4 weeks prior to surgery and 12 weeks post surgery.

次要结局

未报告次要终点

研究者

发起方
Chandan K Sen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chandan K Sen

Professor

Ohio State University

研究点 (4)

Loading locations...

相似试验